secwatch / observer
8-K filed April 5, 2024, 7:59 PM ET ticker TDOC CIK 0001477449
leadership confidence high sentiment neutral materiality 0.70

Teladoc CEO Jason Gorevic departs; CFO Mala Murthy named acting CEO

Teladoc Health, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Mala Murthy

acting Chief Executive Officer
TDOC · Teladoc Health, Inc.
Effective
2024-04-05
Filed
April 5, 2024, 7:59 PM ET
Teladoc Health announced the appointment of Mala Murthy to the position of acting Chief Executive Officer of the Company, effective immediately.
Departed

Jason Gorevic

Chief Executive Officer
TDOC · Teladoc Health, Inc.
Effective
2024-04-05
Successor
Mala Murthy
Filed
April 5, 2024, 7:59 PM ET
replacing Jason Gorevic, who will also depart from the Board of Directors of the Company as required by his employment agreement.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Teladoc Health, Inc. updated its quarter ended March 31, 2024 guidance (reaffirmed).

Period
quarter ended March 31, 2024
Guidance
reaffirmed
Result
preliminary results
Exact text from the filing
On April 5, 2024, Teladoc Health, Inc. (“Teladoc Health” or the “Company”) announced that it continues to expect its outlook for the quarter ended March 31, 2024 and the year ending December 31, 2024 to be consistent with the outlook ranges disclosed in the Company’s earnings release on February 20, 2024. The financial results for the quarter ended March 31, 2024 are preliminary, unaudited and subject to change
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Mala Murthy was appointed as acting Chief Executive Officer at Teladoc Health, Inc..

Action
appointed
Role
acting Chief Executive Officer
Exact text from the filing
Teladoc Health announced the appointment of Mala Murthy to the position of acting Chief Executive Officer of the Company, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jason Gorevic departed as Chief Executive Officer at Teladoc Health, Inc..

Action
departed
Role
Chief Executive Officer
Exact text from the filing
replacing Jason Gorevic, who will also depart from the Board of Directors of the Company as required by his employment agreement.
View on SEC.gov

321 earnings releases filed in the last 30 days. Browse all earnings releases →

Teladoc Health, Inc. filing history →

Source: SEC EDGAR
accession 0001477449-24-000083
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.